Skip to main content
OpenTrials

Clinical trial condition

Epstein-Barr Virus Infections

Explore clinical trials studying Epstein-Barr Virus Infections. Study availability and eligibility vary by location and protocol.

126 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Epstein-Barr Virus Infections trial results

Enrolling by invitation

Comparative Autoantibody and Immunologic Cell Marker Study

NCT02422875

Conditions
Acquired Immunodeficiency Syndrome, Arthritis, Arthritis, Juvenile, +85 more
Locations
  • Emory University Hospital Atlanta, Georgia, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Grady Health System Atlanta, Georgia, United States
View Trial Details
Active, not recruiting

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

NCT02135042

Conditions
Carcinoma, DNA Virus Infections, EBV Infection, +22 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California, United States
View all 213 locations
View Trial Details
Active, not recruiting

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants

NCT05831111

Conditions
DNA Virus Infections, Epstein-Barr Virus Infection, Epstein-Barr Virus Infections, +12 more
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • Noble Clinical Research Tucson, Arizona, United States
  • Marvel Clinical Research Huntington Beach, California, United States
  • Tekton Research Longmont, Colorado, United States
View all 34 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

NCT04554914

Conditions
Allogeneic Hematopoietic Cell Transplant, DNA Virus Infections, EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD), +24 more
Locations
  • University of California Los Angeles (UCLA) (Adults and Pediatrics) Los Angeles, California, United States
  • Children's Hospital of Orange County (Pediatrics [up to 25 years old]) Orange, California, United States
  • Lucile Packard Children's Hospital Stanford (Pediatrics only) Palo Alto, California, United States
  • University of California Davis Comprehensive Cancer Center (Adults and Pediatrics) Sacramento, California, United States
View all 40 locations
View Trial Details
Active, not recruiting

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

NCT05164094

Conditions
DNA Virus Infections, Epstein-Barr Virus Infection, Epstein-Barr Virus Infections, +12 more
Locations
  • Medical Affiliated Research Institute Huntsville, Alabama, United States
  • Smart Cures Clinical Research Anaheim, California, United States
  • Benchmark Research - Colton - HyperCore - PPDS Colton, California, United States
  • Fomat Medical Research Oxnard, California, United States
View all 65 locations
View Trial Details
Active, not recruiting

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

NCT03475212

Conditions
Adenoviridae Infections, Adenovirus Infection, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 30 locations
View Trial Details

Related conditions